DAGLA Antikörper (C-Term)
Kurzübersicht für DAGLA Antikörper (C-Term) (ABIN335130)
Target
Alle DAGLA Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Güteklasse
-
-
Bindungsspezifität
- C-Term
-
Verwendungszweck
- DAGLA
-
Sequenz
- PAKQDELVIS AR
-
Kreuzreaktivität
- Human, Maus, Ratte
-
Aufreinigung
- Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
-
Immunogen
- Peptide with sequence C-PAKQDELVISAR, from the C Terminus of the protein sequence according to NP_006124.1.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
Immunohistochemistry: Paraffin embedded Human Breast, Pancreas and Spleen. Recommended concentration: 5 μg/mL.
Western Blot: Approx 125 kDa band observed in Human Liver lysates (calculated MW of 115 kDa according to NP_006124.1). Recommended concentration: 0.3-1 μg/mL. Some minor background is detected and is blocked by the immunizing peptide. Primary incubation wa
Peptide ELISA: antibody detection limit dilution 1:128000.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.5 mg/mL
-
Buffer
- Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Minimize freezing and thawing.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.
-
-
- DAGLA (Diacylglycerol Lipase, alpha (DAGLA))
-
Andere Bezeichnung
- DAGLA
-
Hintergrund
- DAGLA, diacylglycerol lipase, alpha, C11orf11, DAGL(ALPHA), DAGLALPHA, NSDDR, diacylglycerol lipase alpha, neural stem cell-derived dendrite regulator, KIAA0659
-
Gen-ID
- 747, 269060, 309207
-
NCBI Accession
- NP_006124
Target
-